Agreement Between Innovative Medicines Initiative and Global Alzheimer’s Platform Will Accelerate Alzheimer’s Drug Development

Agreement Between Innovative Medicines Initiative and Global Alzheimer’s Platform Will Accelerate Alzheimer’s Drug Development
shutterstock_74106817The Innovative Medicines Initiative (IMI) together with the Global Alzheimer's Platform (GAP) recently announced the signing of a Memorandum of Understanding (MOU) agreement based on the common goal of accelerating the search for an Alzheimer’s disease therapy through the creation of a global, standing, trial-ready platform for Alzheimer's drug development. The announcement was made at
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *